Company profile: Active Biotech
1.1 - Company Overview
Company description
- Provider of biotechnology research and development of pharmaceuticals and vaccines, based on knowledge of autoimmune/inflammatory diseases and cancer, developing products to treat conditions including multiple sclerosis and lung and renal diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Active Biotech
X-Body Biosciences
HQ: United States
Website
- Description: Provider of biotechnology R&D focused on discovering and developing compounds against therapeutic targets in oncology and ophthalmology, including discovery of human antibodies against high-value targets; engages in alliances with other corporations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X-Body Biosciences company profile →
Eureka Therapeutics
HQ: United States
Website
- Description: Provider of T-cell therapies via the ARTEMIS Cell Receptor Platform to engineer T cells to target and destroy cancer cells; the E-ALPHA Phage Display Platform to generate specific antibodies against cancer targets, including TCR-mimic antibodies for solid tumors; and an Expanded Access Policy offering investigational cell therapy under certain conditions to patients with serious or life-threatening diseases who have no other treatment options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eureka Therapeutics company profile →
Takara Bio
HQ: Japan
Website
- Description: Provider of life science reagents, kits, gene therapy solutions, and contract biology development services. Develops, manufactures, and distributes products under the Takara, Clontech, and Cellartis brands, including SMART cDNA synthesis kits for NGS and other applications, and high-performance qPCR/PCR reagents such as Takara Ex Taq and Takara LA Taq.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Takara Bio company profile →
Alexion
HQ: United States
Website
- Description: Provider of biologic therapies for severe, life-threatening diseases, including hematologic, kidney and neurologic conditions, transplant rejection, cancer and autoimmune disorders; portfolio includes SOLIRIS (PNH, aHUS, NMOSD), ULTOMIRIS (PNH, aHUS), STRENSIQ (HPP) and KANUMA (LAL-D), plus patient support and managed access programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alexion company profile →
Genelux
HQ: United States
Website
- Description: Provider of diagnostic and therapeutic solutions for cancer and inflammatory diseases, featuring oncolytic vaccinia virus programs: Olvi-Vec for ovarian and lung cancers (intraperitoneal or intravenous), V2ACT Immunotherapy combining oncolytic immunotherapy with adoptive cell therapy for pancreatic cancer (systemic), and V-VET1 for canine cancers (intravenous).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genelux company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Active Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Active Biotech
2.2 - Growth funds investing in similar companies to Active Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Active Biotech
4.2 - Public trading comparable groups for Active Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →